Study | Country | Severe criterion | Study Design | Number of Sites | Sample | Mean age(y) | Corticosteroid Type | Corticosteriod Dosage | Cumulative Hydrocortisone Dose (mg)✳ | Corticosteroid duration(d) | |
---|---|---|---|---|---|---|---|---|---|---|---|
n | N | ||||||||||
Confalonier 2005 [9] | Italy | ATS | DB RCT | 6 | 23 | 23 | 63.5 | Hydrocortisone | Intravenous 200 mg IV bolus; followed 10 mg/hour IV | 1880 | 7 |
Snijders 2010 [10] | Netherlands | PSI | DB RCT | 1 | 48 | 45 | 63.51 | Prednisolone | 40 mg oral or IV daily | 1120 | 7 |
Sabry 2011 [11] | Egypt | ATS | DB RCT | 2 | 40 | 40 | 62.22 | Hydrocortisone | 200 mg IV bolus then maintenance dose of 12.5 mg/h | 2300 | 7 |
Sui,DongJiang 2013 [12] | China | BTS | RCT | 1 | 30 | 30 | 62.71 | Methylprednisolone | 40 mg IV twice daily on days 1–3 and 8 mg oral twice daily on days 4–7 | 1440 | 7 |
Torres 2015 [13] | Spain | ATS | DB RCT | 3 | 61 | 59 | 65.29 | Methylprednisolone | 0.5 mg/kg IV twice daily | 1750 | 5 |
Chu,ZiDong 2018 [14] | China | NR | RCT | 1 | 50 | 50 | 70.5 | Methylprednisolone | 40 mg IV twice daily on days 1–3 and 8 mg oral twice daily on days 4–7 | 1440 | 7 |
Wittermans 2021 [15] | Netherlands | PSI | DB RCT | 4 | 77 | 79 | 76.51 | Dexamethason | 6 mg oral daily | 638.4 | 4 |
Meduri 2022 [16] | USA | ATS | DB RCT | 42 | 297 | 287 | 68.8 | Methylprednisolone | 40 mg bolus followed by 40 mg daily on days 1–7, 20 mg daily on days 8–14, 12 mg daily on days 15–17 and 4 mg daily on days 18–20 | 2540 | 20 |
Dequin 2023 [8] | France | PSI | DB RCT | 31 | 400 | 395 | 67 | Hydrocortisone | IV 200 mg daily for either 4 or 8 days, followed by tapering for 8 or 14 days | 1000 | 8/14 |